News
Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...
Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...
The primary endpoints of TROPION-Lung02 are dose-limiting toxicities and treatment-emergent adverse events. Secondary endpoints include ORR, DoR, PFS as assessed by investigator, overall survival, ...
ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...
Pulmonary fibrosis encompasses a spectrum of interstitial lung diseases (ILDs) characterized by chronic inflammation, aberrant tissue remodeling, and ...
Background Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed by the European Respiratory Society and American Thoracic Society Task Force for those patients ...
Dr Martin Riedel, Deutsches Herzzentrum und I. Medizinische Klinik, Technische Universität München, Lazarettstr. 36, D-80636 München, Germanym.riedel{at}dhm.mhn.de If you wish to reuse any or all of ...
Some people have this disease along with sarcoidosis in other parts of the body. Other people have only lung disease. In rare cases, people have sarcoidosis in other parts of the body, but not the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results